Tobacco, oral cancer, and treatment of dependence

Oral Oncology

Volumn 41, Issue 3, 2005, Pages 244-260

  Warnakulasuriya, Saman ^a   Sutherland, Gay ^b   Scully, Crispian ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Addiction; Dependence; Oral cancer; Precancer; Tobacco; Treatment

Indexed keywords

NICOTINE;

CANCER RISK; CARCINOGENICITY; CIGARETTE SMOKING; HUMAN; LOZENGE; MOUTH CANCER; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; TABLET; TOBACCO; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 14644435804     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.08.010     Document Type: Review

References (122)

1. G.H. Brundtland Achieving worldwide tobacco control JAMA 284 2000 750 751
2. World Health Organization. Addressing the Worldwide Tobacco Epidemic through Effective Evidence-Based Treatment. Expert Meeting March 1999, Rochester, Minnesota, USA. Tobacco Free Initiative, WHO 2000
3. K.A.A.S. Warnakulasuriya, C.K. Harris, and D.M. Scarrot An alarming lack of public awareness towards oral cancer Br. Dent. J. 187 1999 319 322
4. G. Yang, L. Fan, and J. Tan Smoking in China. Findings of the 1996 National Prevalence Survey JAMA 282 1999 1247 1253
5. R. Doll, R. Peto, J. Boreham, and I. Sutherland Mortality in relation to smoking: 50 years' observations on male British doctors BMJ 328 2004 1519
6. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of twenty-five major cancers in 1990 Int. J. Cancer 8 1999 827 841
7. C. La Vecchia, A. Tavani, S. Franceschi, F. Levi, G. Corrao, and E. Negri Epidemiology and prevention of oral cancer Oral Oncol. 33 1997 302 312
8. W.J. Blot, J.K. McLaughlin, D.M. Winn, D.F. Austin, Rs. Greenberg, and S. Preston-Martin Smoking and drinking in relation to oral and pharyngeal cancer Cancer Res. 48 1988 3282 3287
9. J. Brugere, P. Guenel, A. Leclerc, and J. Rodriguez Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth Cancer 57 1986 391 395
10. R. Talamani, S. Franceschi, S. Baara, and C. Lavechia The role of alcohol in oral and pharyngeal cancer in nonsmokers, and of tobacco in nondrinkers Int. J. Cancer 46 1990 391 393
11. S. Franceschi, R. Talamani, and S. Baara Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and oesophagus in Northern Italy Cancer Res. 50 1990 6502 6507
12. P. Boffetta, A. Marshberg, R. Winkelmann, and L. Garfinkel Carcinogenic effect of tobacco smoking and alcohol drinking on anatomical sites of the oral cavity and oropharynx Int. J. Cancer 52 1992 530 533
13. E. Negri, C. La Vecchia, S. Franceschi, and A. Tavani Attributable risk for oral cancer in northern Italy Cancer Epidemiol. Biomarkers Prev. 2 1993 189 193
14. F. Merletti, P. Bofetta, G. Ciccone, A. Mashberg, and B. Terracini Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy Cancer Res. 49 1989 4919 4924
15. E. De Stafani, P. Boffetta, F. Oreggia, M. Medilaharsu, and H. Deneo-Pellegrini Smoking patterns and cancer of the oral cavity and pharynx: a case-control study in Uruguay Oral Oncol. 34 1998 340 346
16. N.F. Schlect, E.L. Franco, J. Pintos, A. Negassa, L.P. Kowalski, and B.V. Oliveira Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil Am. J. Epidemiol. 150 1999 1129 1137
17. L.A. Moreno-Lopez, G.C. Esparaza-Gomas, A. Gonzalez-Navarro, R. Cerero-Lapiedra, M.J. Gonzalez-Hernandez, and V. Dominguez-Rojas Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain Oral Oncol. 36 2000 170 174
18. A.I. Zavras, C.W. Douglass, K. Joshipura, T. Wu, G. Laskaris, and E. Petridou Smoking and alcohol in the etiology of oral cancer: gender specific risk profiles in the south of Greece Oral Oncol. 37 2001 28 35
19. C.D. Llewellyn, N.W. Johnson, and S. Warnakulasuriya Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger. A case-control study in Southern England J Oral Pathol Med 33 2004 525 532
20. D.B. Thomas Alcohol as a cause of cancer Environ Health Perspect. 103 1995 153 160
21. P.C. Gupta, F.S. Mehta, and D.K. Daftary Incidence of oral cancer and natural history of precancerous lesions in a 10-yr follow-up study of Indian villagers Comm. Dent. Oral Epidemiol. 8 1980 287 333
22. R. Kulasegaram, M.C. Downer, J.A. Jullien, J.M. Zakrzewska, and P.M. Speight Case-control study of oral dysplasia and risk habits among patients of a dental hospital Comm. Dent. Health 31B 1995 227 231
23. M.A. Jaber, S.R. Porter, M.S. Gilthorpe, R. Bedi, and C. Scully Risk factors for oral epithelial dysplasia-the role of smoking and alcohol Oral Oncol. 35 1999 151 156
24. T.G. Shanks, and D.M. Burns Disease consequences of cigar smoking Smoking and tobacco control monograph 9. Cigars health effects and trends 1998 National Cancer Institute Bethesda, MD 105 158
25. I. Hindle, M. Downer, and P.M. Speight The association between intra-oral cancer and surrogate markers of smoking and alcohol consumption Comm. Dent. Health 17 2000 107 113
26. L.A.M. Lopez, G.C.E. Gomez, A.G. Navarro, R.C. Lapiedra, M.J.G. Hernandez, and V.D. Rojas Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain Oral Oncol. 36 2000 170 174
27. P.C. Gupta A study of dose-response relationship between tobacco habits and oral leukoplakia Br. J. Cancer 50 1984 527 531
28. H.J. Stich, B.B. Parida, and K.D. Brunnemann Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of reverse smokers, khaini tobacco chewers and gudakhu users Int. J. Cancer 50 1992 172 176
29. P.C. Gupta, F.S. Mehta, and J.J. Pindborg Mortality among reverse chutta smokers in South India Br. Med. J. 289 1984 865 866
30. P.C. Gupta, R.B. Bhonsle, F.S. Mehta, and J.J. Pindborg Mortality experience in relation to tobacco chewing and smoking habits from follow up study in Ernakulam District, Kerala Int. J. Epidemiol. 13 1984 184 187
31. M. Rahman, J. Sakamoto, and T. Fukui Bidi smoking and oral cancer: a meta analysis Int. J. Cancer 106 2003 600 604
32. P.C. Gupta, F.S. Mehta, and R.R. Irani Comparison of mortality rates among bidi smokers and tobacco chewers Ind. J. Cancer 17 1980 149 152
33. S. Warnakulasuriya Smokeless tobacco and oral cancer Oral Diseases 10 2004 1 4
34. D.M. Winn, W.J. Blot, C.M. Shy, L.W. Pickle, A. Toledo, and J.F. Fraumeni Snuff dipping and oral cancer among women in the southern United States New Eng. J. Med. 304 1981 745 749
35. T. Axell Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia Oral Oncol. 29B 1993 299 302
36. T. Axell, H. Mornstad, and B. Sundstrom Snuff and cancer of the oral cavity: a retrospective study (in Swedish) Laekartidningen 75 1978 1224 1226
37. Hirsch JM. Snuff induced cancer in Sweden. In: 3rd International Conference on Smokeless Tobacco. Stockholm, Sweden, 22-25 September 2002
38. U.K. Zatterstrom, M. Svensson, L. Sand, H. Nordgren, and J.M. Hirsch Oral cancer after using Swedish snus (smokeless tobacco) for 70 years-a case report Oral Diseases 10 2004 50 53
39. S. Warnakulasuriya Analytical studies of the evaluation of the role of betel-quid in oral carcinogenesis R. Bedi Betel-quid and tobacco chewing among the Bangladeshi community in the United Kingdom 1995 Centre for Transcultural Oral Health London 61 70
40. A.M. Idris, J. Nair, M. Friesen, H. Ohshima, I. Brouet, and E.M. Faustman Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan Carcinogenesis 13 1992 1001 1005
41. X. Zhang, W. Schmitz, H.R. Gelderblom, and P.A. Reichart Shammah-induced oral leukoplakia like lesions Oral Oncol. 37 2001 609 612
42. W.F. Allard, E.B. De Vol, and O.B. Te Smokeless tobacco (shamma) and oral cancer in Saudi Arabia Comm. Dent. Oral Epidemiol. 27 1999 398 405
43. IARC. Tobacco habits other than smoking; Betel quid, areca nut chewing and some related nitrosamines. IARC monograph, vol. 37, IARC, Lyon, 1985. p. 37-136
44. Warnkulasuriya S. Smokeless tobacco use following migration and its consequences. In: 2nd International Conference on Smokeless/Spit Tobacco, National Cancer Institute, Bethesda, Maryland, 2002. p. 13-5
45. K.A.A.S. Warnakulasuriya, N.W. Johnson, K.M. Linklater, and J. Bell Cancer of the mouth, pharynx and nasopharynx in Asian and Chinese immigrants resident in Thames regions Oral Oncol. 35B 1999 471 475
46. A. Dipple, R.C. Moschel, and A.H. Bigger Polynuclear aromatic hydrocarbons C.E. Searl Chemical Carcinogenesis 182 1984 American Chemical Society Monograph Washington, DC 41 163
47. J. Nair, H. Ohshima, M. Friesen, A. Croisy, S.V. Bhide, and H. Bartsch Tobacco specific and betel nut specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid Carcinogenesis 6 1985 295 303
48. D. Hoffman, and S.S. Hect Nicotine derived N-nitrosamines and tobacco related cancer: current status and future direction Cancer Res. 45 1985 935 944
49. U. Lin, K. Sundquist, S.A. Belinsky, A. Castonguay, H. Tjalve, and R.C. Graftstrom Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butone in cultured explants and epithelial cells of human buccal mucosa Carcinogenesis 14 1993 2383 2388
50. D. Hoffman, A. Rivenson, and S.S. Hect Carcinogenesis of smokeless tobacco Smoking and Tobacco Control Monograph No. 2 1993 US National Institute of Health Bethesda, MD
51. H. Bartch, M. Rojas, U. Nair, J. Nair, and K. Alexandrov Genetic cancer susceptibility and DNA adducts. Studies of smokers, tobacco chewers, and coke oven workers Cancer Detect. Prevent. 23 1999 445 453
52. C.D. Llewellyn, N.W. Johnson, and K.A.A.S. Warnakulasuriya Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review Oral Oncol. 37 2001 401 408
53. C. Scully, J.K. Field, and H. Tanzawa Genetic aberrations in oral or head and neck squamous cell carcinoma carcinogen (SCCHN): 1. Metabolism. DNA repair and cell cycle control Oral Oncol. 36 2000 256 263
54. S. Warnakulasuriya Cancers of the oral cavity and pharynx B. Vogelstein K.W. Kinzler The genetic basis of human cancer 2002 McGraw-Hill 773 784
55. US Department of Health and Human Services, Office of Smoking and Health. The health consequences of smoking: Nicotine addiction. A Report of he US Surgeon General, US Government Printing Office, Washington, DC, 1988, p. 7-8, 270, 334-5
56. I.P. Stolerman, and M.J. Jarvis The scientific case that nicotine is addictive Psychopharmacology 117 1995 2 10
57. M.A.H. Russell, M.J. Jarvis, G. Devitt, and C. Feyerabend Nicotine intake by snuff users Br. Med. J. 283 1981 814 817
58. N.L. Benowitz, H. Porchet, L. Sheiner, and P. Jacob Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum Clin. Pharmacol. Ther. 44 1988 23 28
59. D.K. Hatsukami, S.W. Gust, and R.M. Keenan Physiologic and subjective changes from smokeless tobacco withdrawal Clin. Pharmacol. Ther. 41 1987 103 107
60. W.A. Corrigall, K.B.J. Franklin, K.M. Coen, and P.B.S. Clarke The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine Psychopharmacology 107 1992 285 289
61. S. Shiffman, L.B. Fisher, M. Zettler-Segal, and N.L. Benowitz Nicotine exposure among nondependent smokers Arch. Gen. Psychiatry 47 1990 333 336
62. N.L. Benowitz, Jacob III, C. Denaro, and R. Jenkins Stable isotope studies of nicotine kinetics and bioavailability Clin. Pharmacol. Ther. 49 1991 270 277
63. Department of Health and Human Services. Public Health Service. The health consequences of smoking: Nicotine Addiction: a report of the Surgeon General. Government Printing Office, Washington, DC, 1998 (DHSS Pub. no. 88-8406)
64. H.H. Severson, E.G. Eakin, V.J. Stevens, and E. Lichtenstein Dental office practices for tobacco users: independent practice and HMO clinics Am. J. Pub. Health 80 1990 1503 1505
65. S.L. Tomar, C.G. Husten, and M.W. Manley Do dentists and physicians advise tobacco users to quit JADA 127 1996 259 265
66. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. US Department of Health and Human Services. Public Health Service, Rockville, MD, June 2000
67. R. West Assessment of tobacco dependence and motivation to stop smoking Br. Med. J. 328 2004 338 339
68. R. West, A. McNeill, and M. Raw Smoking cessation guidelines for health professionals: an update Thorax 55 2000 987 999
69. J.O. Prochaska, and C.C. DiClemente Stages of change in the modification of problem behaviours M. Hersen R.M. Eisler P.M. Miller Progress on behaviour modification 1992 Sycamore Publishing Sycamore, IL 27 76
70. W. Miller, and S. Rollick Motivational interviewing; preparing people to change. Addictive behaviour 1991 Guilford New York, NY
71. S.M. Colby, P.M. Monty, and N.P. Barnett Brief motivational interviewing in a hospital setting for adolescent smoking; a preliminary study J. Consult. Clin. Psychol. 66 1998 574 578
72. R. West Assessment of dependence and motivation to stop smoking Br. Med. J. 328 2004 338 339
73. K.O. Fagerstrom, and N.G. Schneider Measuring nicotine dependence; a review of the Fagerstrom Tolerance questionnaire J. Behav. Med. 12 1989 159 182
74. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrom The Fagerstrom test for nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire Br. J. Addict. 86 1991 119 127
75. L.T. Kozlowski, C.Q. Porter, C.T. Orleans, M.A. Pope, and T. Heatherton Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI Drug & Alcohol Dependence 34 1994 211 216
76. J.E. Henningfield Nicotine medications for smoking cessation New Eng. J. Med. 333 1995 1196 1203
77. G. Sutherland Evidence for counselling effectiveness for smoking cessation J. Clin. Psych Monograph 18 2003 22 34
78. D.J. Reid, A.J. Killoran, A.D. McNeil, and J.S. Chambers Choosing the most effective health promotion options for reducing a nation's smoking prevalence Tobacco Control 1 1992 185 187
79. J.A. Austoker, D. Saunders, and G. Fowler Smoking and cancer: smoking cessation Br. Med. J. 308 1994 1478 1482
80. C. Silagy, T. Lancaster, L. Stead, D. Mant, and G. Fowler Nicotine replacement therapy for smoking cessation The Cochrane Database of Systematic Reviews 2004 Issue 3
81. J.C. Cantor, C.C. Baker, and R.G. Hughes Preparedness for practice: young physicians' views of their professional education JAMA 270 1993 1035 1040
82. K.A.A.S. Warnakulasuriya, and N.W. Johnson Dentists and oral cancer prevention in the UK: opinions, attitudes and practices to screening for oral mucosal lesions and to counselling patients on tobacco and alcohol use: base line data from 1991 Oral Diseases 5 1999 10 14
83. A.M. Horowitz, T.F. Drury, H.S. Goodman, and J.A. Yellowitz Oral and pharyngeal cancer prevention and early detection: Dentists opinions and practices JADA 131 2000 453 461
84. C.H. Denny, M.K. Serdula, D. Holtzman, and D.E. Nelson Physician advice about smoking and drinking; are US adults being informed? Am. J. Prev. Med. 24 2003 71 74
85. S. Warnakulasuriya Effectiveness of tobacco counselling in the dental office: an overview J. Dent. Ed. 66 2002 1080 1089
86. Yaraghi K, Warnakulasuriya S. Characteristics of patients attending a dysplasia clinic; An audit of risk factors and outcome. J Dent Res, Abstract, March, 2003
87. R. West Addressing regulatory barriers to licensing nicotine products for smoking reduction Addiction 95 Suppl 1 2000 S29 S34
88. National Institute for Clinical Excellence. Technology Appraisal Guidance - No. 39 Guidance on the use of Nicotine replacement therapy (NRT) and Bupropion for smoking cessation, 2002
89. G. Sutherland, M.A.H. Russell, J. Stapleton, C. Feyerabend, and O. Fernö Nasal nicotine spray: A rapid delivery system Psychopharmacology 108 1992 512 518
90. G. Sutherland, J.A. Stapleton, M.A.H. Russell, M.J. Jarvis, P. Hajek, and M. Belcher Randomised controlled trial of nasal nicotine spray in smoking cessation Lancet 340 1992 324 329
91. Foulds J. Nicotine replacement therapy: availability, abuse liability and dependence potential. In: Smith CT, editor. Tackling tobacco. Health Promotion Wales, Cardiff, 1999. p. 11-6
92. Editorial. The nicotine use after the year 2000. The Lancet 1991;337:1191-2
93. Hoffman Nicotine, a tobacco-specific precursor for carcinogens N. Wald P. Froggatt Nicotine, smoking and the low tar programme 1989 Oxford University Press Oxford 29 40
94. R.D. Hurt, D.P.L. Sachs, E.D. Glover, K.P. Offord, J.A. Johnston, and L.C. Dale A comparison of sustained-release bupropion and placebo for smoking cessation New Eng. J. Med. 337 1997 1195 1202
95. D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, and A.R. Hughes A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation New Eng. J. Med. 340 1999 685 691
96. E. Roddy Bupropion and other non-nicotine pharmacotherapies Br. Med. J. 328 2004 509 511
97. L.C. Dale, J.O. Ebbert, D.R. Schroeder, I.T. Croghan, D.F. Rasmussen, and J.A. Trautman Bupropion for the treatment of nicotine dependence in spit tobacco users: A pilot study Nicotine Tobacco Res. 4 2002 267 274
98. E.D. Glover, P.N. Glover, C.R. Sullivan, C.L. Cerullo, and G. Hobbs A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation Am. J. Health Behav. 26 2002 386 393
99. N.C. Abbot, L.F. Stead, A.R. White, and J. Barnes Hypnotherapy for smoking cessation The Cochrane Database of Systematic Reviews 1998 Issue 2
100. S. Shiffman, J.A. Paly, and J.M. Rohay The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy Arch. Intern. Med. 160 2000 1675 1681
101. M.J. Jarvis Patterns and predictors of smoking cessation in the general population C.T. Bolliger K.O. Fagerström The tobacco epidemic (Progress in Respiratory Research) 1997 Karger Basel 151 164
102. M.J. Jarvis, J. Wardle, J. Waller, and L. Owen Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study Br. Med. J. 326 2003 1061 1065
103. Severson HH. Enough Snuff: ST cessation from the behavioral, clinical, and public health perspectives. Smoking and Tobacco Control Monograph 2: Smokeless tobacco or health: An international perspective. National Cancer Institute, US Department of Health and Human Services, 1992
104. R. West, A. McNeill, and M. Raw Smokeless tobacco cessation guideline for health professionals in England Br. Dent. J. 196 2004 611 618
105. E. Eakin, and H. Severson Development and evaluation of a smokeless tobacco cessation program: A pilot study Natl. Cancer Inst. Monographs 8 1989 95 100
106. T.M. DiLorenzo, and T.G. Kern Treatment of smokeless tobacco use through a formalized cessation program Behav. Therapy 22 1991 41 46
107. J.C. Greene, M.M. Walsh, and C. Masouredis A program to help major-league baseball players quit using spit tobacco JADA 125 1994 559 568
108. V.J. Stevens, H. Severson, E. Lichtenstein, S.J. Little, and J. Leben Making the most of a teachable moment: A smokeless-tobacco cessation intervention in the dental office Amer. J. Pub. Health 85 1995 231 235
109. H.H. Severson, J.A. Andrews, E. Lichtenstein, J.S. Gordon, M. Barckley, and L. Akers A self-help cessation program for smokeless tobacco users: Comparison of two interventions Nicotine Tobacco Res. 2 2000 363 370
110. D. Hatsukami, J. Jensen, S. Allen, M. Grillo, and R. Bliss Effects of behavioral and pharmacological treatment on smokeless tobacco users J. Consult. Clin. Psychol. 64 1996 153 161
111. D.K. Hatsukami, M. Grillo, R. Boyle, S. Allen, J. Jensen, and R. Bliss Treatment of spit tobacco users with transdermal nicotine system and mint snuff J. Consult. Clin. Psychol. 68 2000 241 249
112. R.C. Stotts, P.K. Roberson, E.Y. Hanna, S.K. Jones, and C.K. Smith A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents Tobacco Control 12 Suppl 4 2003 IV11 IV15
113. R. Croucher, S. Islam, M.J. Jarvis, M. Garrett, R. Rahman, and S. Shajahan Oral tobacco cessation with UK resident Bangladeshi women: a community pilot investigation Health Ed. Res. 18 2003 216 223
114. J.O. Ebbert, L.C. Rowland, V.M. Montori, K.S. Vickers, P.J. Erwin, and L.C. Dale Treatments for spit tobacco use: a quantitative systematic review Addiction 98 2003 569 583
115. P.C. Gupta, F.S. Mehta, and J.J. Pindborg Primary prevention trial on oral cancer in India: A 10 year follow up study J. Oral Pathol. Med. 21 1992 433 439
116. P.C. Gupta, P.R. Murti, R.B. Bhonsle, F.S. Mehta, and J.J. Pindborg Effect of cessation of tobacco use on the incidence of oral mucosal lesions in a 10-yr follow up study of 12 212 users Oral Diseases 1 1995 54 58
117. P.C. Gupta, and C. Ray Smokeless tobacco and health in India and south Asia Respirology 8 2003 419 431
118. R. Ahuja, S.B. Weibel, and F.T. Leone Lung cancer: the oncologist's role in smoking cessation Semin. Oncol. 30 2003 94 103
119. Y.I. Garces, and J.T. Hays Tobacco dependence; why should an oncologist care J. Clin. Oncol. 21 2003 1884 1886
120. C.M. Blanchard, M.M. Denniston, F. Baker, S.R. Ainsworth, K.S. Courneya, and D.M. Hann Do adults change their lifestyle behaviours after a cancer diagnosis Am. J. Health Behav. 27 2003 246 256
121. R.A. Schnoll, B. Zhang, M. Rue, J.E. Krook, W.T. Spears, and A.C. Marcus Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group J. Clin. Oncol. 21 2003 355 365
122. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. Tobacco Smoke and Involuntary Smoking. IARC, Lyon, 2004, p. 81-2